Prof. Daniela Wesch and Prof. Matthias Peipp appointed as scientific advisors
4. July 2021
Prof. Wesch and Prof. Peipp (both UKSH, Kiel), renowned experts in immune-oncology, gamma delta T cells and antibody development have agreed in sharing their scientific expertise and becoming advisors to monitor and support the scientific activities at Evobright.
“As we have a highly productive interaction with Prof. Wesch and Prof. Peipp for Evobrights R&D activities already it was a logical next step to ask both experts to become Evobrights first scientific advisors” explains COO Dr. Christoph Baumann. “Klaus-Peter and Christoph have huge experience in drug development document by their numerous patents and publications. It is a pleasure to complement that with our long standing expertise in gamma delta T cells, antibody design and generation, and tumor immuno-oncology” says Prof. Wesch.